C. Pike

发表

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Ronald C Kessler, R. Kessler, P. Greenberg, 2015, The Journal of clinical psychiatry.

Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies

C. Piech, P. Lefebvre, C. Pike, 2017 .

Assessing the Potential Anti-Neuroinflammatory Effect of Minocycline in Chronic Low Back Pain: Protocol for a randomized, double-blind, placebo-controlled trial

V. Napadow, J. Locascio, M. Loggia, 2022, medRxiv.

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

H. Birnbaum, R. Natale, C. Pike, 2012, Chemotherapy research and practice.

Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US

Hari Sharma, Matt Schiller, Howard G. Birnbaum, 2012, PharmacoEconomics.

Societal cost of rheumatoid arthritis patients in the US

H. Birnbaum, C. Pike, M. Cifaldi, 2010, Current medical research and opinion.

Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006

H. Birnbaum, C. Pike, M. Cifaldi, 2012, PharmacoEconomics.

Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

H. Birnbaum, Lizheng Shi, C. Pike, 2009 .

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US

H. Birnbaum, R. Burge, E. Swallow, 2011, Osteoporosis International.

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US

H. Birnbaum, R. Burge, E. Swallow, 2010, Osteoporosis International.

Employer Model of Workplace Impacts of Anti-TNF Therapy for Rheumatoid Arthritis

H. Birnbaum, C. Pike, M. Cifaldi, 2009, Journal of occupational and environmental medicine.